C3 and metabolic dysfunction-associated steatotic liver disease: Serum complement C3 levels remained to be significantly higher in NAFLD patients compared with those without (1.24 (1.15–1.33) g/L vs. 1.12 (1.04–1.22) g/L, P < 0.001).